We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go: Expired investment: Withheld
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
Holidaymakers tend to return home with around £110 in foreign currency, which tends to go un-exchanged possibly due to hidden fees, lack of ease and simplicity, or poor buy-back rates. Bedwig aims to solve this issue by creating a P2P platform for buyers and sellers to exchange unused currency whilst taking a commission to support the service.
days to go: Expired investment: £39,570
Kwikpay is the first app in the UK to make it easy to top up your prepaid mobiles and prepaid services. Kwikpay have relationships with all major UK mobile operators, as well as mobile operators for another 100 countries.  
days to go: Expired investment: £168,821
Fast-tracking ideas by connecting innovators and organisations together on a single platform. WorldLabs is helping the development of innovations by streamlining the process of those seeking funding and resources to make changes in the world. The company has already partnered with establishments such as UCL and Cambridge University. WorldLab's ecosystem is designed to assist innovators in raising awareness for their initiatives and collaborate with businesses that support the idea. To date, almost 7,000 members are signed up to the platform, with more than 1,000 live projects listed. Funds will be used to increase the number of partnerships with international universities and institutions, as well as develop a mobile app with sophisticated features such as machine learning algorithms.
days to go: Expired investment: £527,943
VINEX is a digital Business-To-Business (B2B) trading platform that connects buyers and sellers to source, sample, negotiate and execute contracts related to wine. The company has traded more than 115 million bottles of wine across 26 countries since 2016. It has also witnessed 3,200 monthly visitors on its platform with an average of 80 million litres of wine traded each month, from 16 countries. The company recently launched VINPay, an industry-first financial technology service customised for the wine industry, providing wineries with guaranteed payment and increased access to capital liquidity. VINEX argues that VINPay pays wineries in 3 days from dispatch, rather than them waiting for 90+ days, and removes non-payment risk. The company points out that it has already started processing invoices, making and receiving payments from 7 countries. VINEX aims to become a contender in the wholesale wine market that is set to exceed US$381 billion in 2021. It will use the investment to help wineries invest and flourish.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £159,720
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph